Cite
HARVARD Citation
Van Vollenhoven, R. et al. (2014). AB0496 Corticosteroid Use across 52 Weeks of Belimumab Therapy in SLE Patients with High Disease Activity: Combined Analyses from the BLISS Trials. Annals of the rheumatic diseases. p. 971. [Online].